Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-07-08, Stock:JNJ, The news for the past five days is as follows:
2020-06-30: nan
2020-07-01: NEWS1: New FDA Guidance May Not Allow Covid-19 Vaccine This Year, Analyst Says.NEWS2: Better Buy: Eli Lilly vs. Johnson & Johnson.NEWS3: Love Dividends? 3 Stocks You Might Want to Buy.NEWS4: This Under-the-Radar Stock Is a Better Way to Bet on Coronavirus Vaccines.
2020-07-02: NEWS1: Were Hedge Funds Right About Cutting Johnson & Johnson (JNJ)?.NEWS2: The Number of Covid-19 Cases Is Rising. What Comes Next..NEWS3: Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses.NEWS4: Pedal to the Metal Leads to Record Rebound.NEWS5: Keep an Eye on Royalty Pharma Stock, 2020’s Biggest IPO.NEWS6: Buy Opko Stock For Two Ways to Play the Ongoing Pandemic.NEWS7: Will Legal Problems Bankrupt Johnson & Johnson?.
2020-07-06: NEWS1: The Kiplinger Dividend 15: Our Favorite Dividend-Paying Stocks.NEWS2: Jabil Inc. -- Moody's assigns Baa3 to Jabil's new senior notes.NEWS3: Catalent plant in Italy will help produce J&J's potential COVID-19 vaccine - minister.NEWS4: Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries.NEWS5: Johnson & Johnson cuts price of TB drug bedaquiline in poorer countries.NEWS6: 3 Stocks I'm Never Selling.NEWS7: Emergent BioSolutions inks coronavirus vaccine manufacturing deal with J&J.NEWS8: Emergent signs five-year deal backing J&J COVID-19 vaccine.NEWS9: Emergent to make drug substance for J&J's COVID-19 vaccine candidate.
2020-07-07: NEWS1: Johnson & Johnson (JNJ) Stock Moves -0.09%: What You Should Know.NEWS2: Emergent's (EBS) 5-Year Deal to Back J&J's Coronavirus Vaccine.NEWS3: U.S. government awards Novavax $1.6 billion for coronavirus vaccine.

Answer: Rise